Why Morgan Stanley likes Gilead's HIV prevention play

After sessions with Gilead's leadership at Morgan Stanley's 2026 Global Healthcare Conference, the bank reaffirmed its Overweight rating, and one franchise stood out.

CryptoAlerta — análise de criptomoedas e mercado em tempo real